Mercator Medical S.A. (WSE:MRC) commences share repurchases on June 1, 2021, under the program mandated by the shareholders in the Annual General Meeting held on April 20, 2021. As per the mandate, the company is authorized to repurchase up to 624,050 shares. The shares will be repurchased at a price falling in the price range from PLN 770 per share to PLN 500 per share. The share repurchase price shall not be higher than the reserve capital created for this purpose. The purpose of repurchase program is to reduce the Company's share capital by redeeming the purchased shares. The repurchase of shares will be financed from funds from the company's reserve capital allocated for the purpose. The repurchase program will be valid one year from the shareholders meeting.